Adcetris Intravenous infusion 50mg, manufactured by Takeda Pharmaceutical, contains Brentuximab vedotin. With YJ code 4291425D1021 and standard 50mg bottle, it is an antibody-drug conjugate indicated for the treatment of classical Hodgkin lymphoma and systemic anaplastic large cell lymphoma.
Adcetris Intravenous infusion 50mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →